These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15301899)

  • 1. Atherosclerotic disease regression with statins: studies using vascular markers.
    Grobbee DE; Bots ML
    Int J Cardiol; 2004 Sep; 96(3):447-59. PubMed ID: 15301899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-altering therapies and the progression of atherosclerotic disease.
    Wierzbicki AS
    Cardiovasc Intervent Radiol; 2007; 30(2):155-60. PubMed ID: 17206389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
    Nissen SE
    Am J Cardiol; 2005 Sep; 96(5A):61F-68F. PubMed ID: 16126025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An emerging paradigm in atherosclerosis: focus on subclinical disease.
    Miller M
    Postgrad Med; 2009 Mar; 121(2):49-59. PubMed ID: 19332962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy.
    Rajaram V; Pandhya S; Patel S; Meyer PM; Goldin M; Feinstein MJ; Neems R; Liebson PR; Fiedler BM; Macioch JE; Feinstein SB
    Am J Cardiol; 2004 Jun; 93(11A):32C-48C. PubMed ID: 15178515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated non-invasive imaging techniques.
    Prati F; Mallus MT; Broglia L; Albertucci M
    EuroIntervention; 2010 May; 6 Suppl G():G161-8. PubMed ID: 20542824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS).
    Van Mieghem CA; McFadden EP; de Feyter PJ; Bruining N; Schaar JA; Mollet NR; Cademartiri F; Goedhart D; de Winter S; Granillo GR; Valgimigli M; Mastik F; van der Steen AF; van der Giessen WJ; Sianos G; Backx B; Morel MA; van Es GA; Zalewski A; Serruys PW
    J Am Coll Cardiol; 2006 Mar; 47(6):1134-42. PubMed ID: 16545642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of advanced cardiac imaging methods in coronary artery disease].
    Kiraç S
    Anadolu Kardiyol Derg; 2008 Jul; 8 Suppl 1():1-4. PubMed ID: 18611832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imaging of atherosclerosis].
    Casella G; Prati F; Klauss V; Coutsoumbas G; Di Pasquale G
    G Ital Cardiol (Rome); 2009 Dec; 10(11-12 Suppl 3):4S-12S. PubMed ID: 21298855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of atherosclerosis: magnetic resonance imaging.
    Corti R; Fuster V
    Eur Heart J; 2011 Jul; 32(14):1709-19b. PubMed ID: 21508002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and LDL-cholesterol lowering: an overview.
    Stroes E
    Curr Med Res Opin; 2005; 21 Suppl 6():S9-16. PubMed ID: 16138936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis imaging.
    Tardif JC
    Can J Cardiol; 2005 Oct; 21(12):1035-9. PubMed ID: 16234886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
    Taylor AJ
    Am J Cardiol; 2008 Apr; 101(8A):36B-43B. PubMed ID: 18375240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of statins in reversing atherosclerosis: what the latest regression studies show.
    Grines CL
    J Interv Cardiol; 2006 Feb; 19(1):3-9. PubMed ID: 16483333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.
    Corti R
    Pharmacol Ther; 2006 Apr; 110(1):57-70. PubMed ID: 16445985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of myocardial ischemia with simvastatin in addition to conventional treatment in patients with chronic coronary artery disease.
    Verri V; Cunha AB; Tessarolo LE; Carneiro RC; Romêo Filho LJ
    Rev Port Cardiol; 2004 Sep; 23(9):1089-105. PubMed ID: 15587571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
    Girotra S; Murarka S; Migrino RQ
    Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of vulnerable coronary artery plaques.
    Hamdan A; Assali A; Fuchs S; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):65-74. PubMed ID: 17585387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.